ES2075016T3 - La subunidad alfa del receptor de adherencia a leucocitos lfa-1. - Google Patents

La subunidad alfa del receptor de adherencia a leucocitos lfa-1.

Info

Publication number
ES2075016T3
ES2075016T3 ES89115160T ES89115160T ES2075016T3 ES 2075016 T3 ES2075016 T3 ES 2075016T3 ES 89115160 T ES89115160 T ES 89115160T ES 89115160 T ES89115160 T ES 89115160T ES 2075016 T3 ES2075016 T3 ES 2075016T3
Authority
ES
Spain
Prior art keywords
lfa
molecules
leukocytes
adherence
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89115160T
Other languages
English (en)
Inventor
Timothy Alan Springer
Richard Larson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dana Farber Cancer Institute Inc
Original Assignee
Dana Farber Cancer Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Institute Inc filed Critical Dana Farber Cancer Institute Inc
Application granted granted Critical
Publication of ES2075016T3 publication Critical patent/ES2075016T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C07K14/70553—Integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)

Abstract

EL PRESENTE INVENTO SE REFIERE A LA SUBUNIDAD - ALFA LFA - 1 QUE ESTA INVOLUCRADA EN EL PROCESO A TRAVES DEL CUAL LA CELULA RECONOCE Y MIGRA HACIA LUGARES DE INFLAMACION ASI COMO SE SUJETA A SUBSTRATOS CELULARES DURANTE LAS INFLAMACIONES. EL INVENTO SE DIRIGE HACIA TALES MOLECULAS, LOS DERIVADOS FUNCIONALES DE TALES MOLECULAS, ENSAYOS PARA IDENTIFICAR TALES MOLECULAS Y USOS TERAPEUTICOS Y DIAGNOSTICOS PARA TALES MOLECULAS.
ES89115160T 1988-08-23 1989-08-17 La subunidad alfa del receptor de adherencia a leucocitos lfa-1. Expired - Lifetime ES2075016T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23522788A 1988-08-23 1988-08-23
US32101789A 1989-03-09 1989-03-09

Publications (1)

Publication Number Publication Date
ES2075016T3 true ES2075016T3 (es) 1995-10-01

Family

ID=26928699

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89115160T Expired - Lifetime ES2075016T3 (es) 1988-08-23 1989-08-17 La subunidad alfa del receptor de adherencia a leucocitos lfa-1.

Country Status (14)

Country Link
EP (1) EP0362526B1 (es)
JP (1) JPH02306999A (es)
KR (1) KR900002796A (es)
AT (1) ATE123810T1 (es)
AU (1) AU634974B2 (es)
DE (1) DE68923048T2 (es)
DK (1) DK412589A (es)
ES (1) ES2075016T3 (es)
FI (1) FI893916A7 (es)
GR (1) GR3017303T3 (es)
HU (1) HUT53673A (es)
IL (1) IL91369A (es)
NO (1) NO893366L (es)
PT (1) PT91503B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0303692A4 (en) * 1987-02-26 1990-12-05 Dana Farber Cancer Institute Cloning of lfa-1
US5395929A (en) * 1987-12-15 1995-03-07 Dana Farber Cancer Institute Isolated nucleic acid encoding the alpha subunit of the human leukocyte adhesion receptor
ZA896668B (en) * 1988-09-01 1990-06-27 Molecular Therapeutics Inc A human rhinovirus receptor protein that inhibits virus infectivity
US6143298A (en) * 1988-09-01 2000-11-07 Bayer Corporation Soluble truncated forms of ICAM-1
US6051231A (en) * 1988-09-01 2000-04-18 Bayer Corporation Antiviral methods and prepations
US6514936B1 (en) 1988-09-01 2003-02-04 Bayer Corporation Antiviral methods using human rhinovirus receptor (ICAM-1)
ES2141076T3 (es) 1988-09-01 2000-03-16 Bayer Ag Proteina del receptor de rinovirus humano que inhibe la infectividad del virus.
ZA901842B (en) * 1989-03-09 1990-12-28 Boehringer Ingelheim Pharma Use of intercellular adhesion molecules,and their binding ligans in the treatment of asthma
JPH04505009A (ja) * 1989-03-09 1992-09-03 ダナ・ファーバー・キャンサー・インスティチュート クローニングｌｆａ―１
US6107461A (en) * 1990-07-20 2000-08-22 Bayer Corporation Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use
US5686581A (en) * 1990-07-20 1997-11-11 Bayer Corporation Multimeric form of human rhinovirus receptor protein
US5686582A (en) * 1990-07-20 1997-11-11 Bayer Corporation Multimeric forms of human rhinovirus receptor protein
ES2134762T3 (es) * 1990-07-20 1999-10-16 Bayer Ag Formas multimericas de proteinas receptoras de rinovirus humanos.
US5120830A (en) * 1990-10-25 1992-06-09 Washington University Inhibitory peptides against α-2, β-1 mediated mg++ dependent adhesion of platelets to collagen
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
US5629287A (en) * 1991-01-18 1997-05-13 University College London Depot formulations
WO1995028170A1 (en) * 1994-04-19 1995-10-26 The University Of Kansas Icam-1/lfa-1 short-chain peptides and method of using same
US6017734A (en) * 1995-07-07 2000-01-25 The Texas A & M University System Unique nucleotide and amino acid sequence and uses thereof
US6075004A (en) * 1996-04-26 2000-06-13 The University Of Kansas Peptide compositions which induce immune tolerance and methods of use
AU4825699A (en) * 1998-06-19 2000-01-05 Genzyme Corporation Identification and use of differentially expressed genes and polynucleotide sequences
CA2346742A1 (en) * 1998-07-06 2000-01-13 University Of Utah Research Foundation Hyaluronic acid mimics and methods related thereto
ATE414715T1 (de) * 2003-09-04 2008-12-15 Biomay Ag Hypoallergene polypeptide basierend auf aus fisch gewonnenem parvalbumin
CA2544678C (en) 2003-11-05 2013-12-31 Sunesis Pharmaceuticals, Inc. Modulators of cellular adhesion
AU2005214382B2 (en) 2004-02-19 2011-08-04 Genentech, Inc. CDR-repaired antibodies
DK2444079T3 (en) 2005-05-17 2017-01-30 Sarcode Bioscience Inc Compositions and Methods for the Treatment of Eye Diseases
ES2830024T3 (es) 2007-10-19 2021-06-02 Novartis Ag Composiciones y métodos para el tratamiento del edema macular
WO2009139817A2 (en) 2008-04-15 2009-11-19 Sarcode Corporation Crystalline pharmaceutical and methods of preparation and use thereof
WO2011050175A1 (en) 2009-10-21 2011-04-28 Sarcode Corporation Crystalline pharmaceutical and methods of preparation and use thereof
KR20200108932A (ko) 2012-07-25 2020-09-21 에스에이알코드 바이오사이언스 인코포레이티드 Lfa-1 저해제 및 그의 다형체

Also Published As

Publication number Publication date
EP0362526A2 (en) 1990-04-11
HUT53673A (en) 1990-11-28
JPH02306999A (ja) 1990-12-20
DE68923048T2 (de) 1995-11-16
DE68923048D1 (de) 1995-07-20
EP0362526B1 (en) 1995-06-14
IL91369A (en) 1994-08-26
AU634974B2 (en) 1993-03-11
DK412589D0 (da) 1989-08-22
FI893916A0 (fi) 1989-08-21
FI893916L (fi) 1990-02-24
ATE123810T1 (de) 1995-06-15
NO893366D0 (no) 1989-08-22
AU4014589A (en) 1990-03-01
PT91503B (pt) 1996-04-30
EP0362526A3 (en) 1990-07-18
NO893366L (no) 1990-02-26
KR900002796A (ko) 1990-03-23
GR3017303T3 (en) 1995-12-31
IL91369A0 (en) 1990-04-29
FI893916A7 (fi) 1990-02-24
PT91503A (pt) 1990-03-08
DK412589A (da) 1990-02-24

Similar Documents

Publication Publication Date Title
ES2075016T3 (es) La subunidad alfa del receptor de adherencia a leucocitos lfa-1.
ES2077572T3 (es) Moleculas de adhesion intercelular, y sus ligandos de fijacion.
ES2080044T3 (es) Moleculas de adhesion intercelular y sus ligandos de fijacion.
JPS57501528A (es)
ES2086313T3 (es) Nuevos derivados de xantina con efecto antagonista de adenosina.
ES2186059T3 (es) Empleo de ectoina e hidroxiectoina como medicamento.
DK135305B (da) N-substituerede-p-menthan-3-carboxamider til anvendelse som middel til fremkaldning af en fysiologisk kuldeeffekt på huden eller slimhinderne af det menneskelige legeme.
ES2054988T3 (es) Quinuclidinas, su empleo como medicamentos y procedimiento para su produccion.
MX146311A (es) Dispositivo intrauterino para el puerperioinmediato para el control de la fertilidad humana
ES2179945T3 (es) Compuestos de tetralina con actividad de resistencia a multiples farmacos.
ES2054716T3 (es) Bis-naftalimidas, su obtencion y empleo.
DK0668933T3 (da) Anvendelse af methioninase som antitumormiddel i antimethioninkemoterapi
ES2072251T3 (es) Composiciones y metodos para la sintesis y ensayo de enquefalinasa.
ES8200560A1 (es) Un procedimiento para producir interferon de fibroblasto hu-mano
AR003438A1 (es) Aminometilcromanos sustituidos por benzoisotiazolilo, procedimiento para su produccion, medicamentos que los contienen, procedimiento para la produccion delos medicamentos, uso de los mismos para tratamiento del sistema nervioso central.
BR8107668A (pt) Processo para a producao de compostos,bem como composicoes de vedacao e composicoes de colagem a base desses compostos
ES444972A1 (es) Aparato de proteccion con reles.
NO885807D0 (no) Gelsammensetning.
MX9306032A (es) Adenosinas 2-sustituidas con afinidad por el receptor a-2.
ES2036523T3 (es) 4-aminoarildihidropiridinlactonas, procedimiento para su obtencion y su empleo en medicamentos.
GT197960582A (es) Nuevos derivados de aminoalquilfurano,procedimiento para su preparacion, asi como su empleo en terapeutica
ES2037657T3 (es) 4-tienil-dihidropiridinas, procedimiento para su preparacion y su aplicacion en medicamentos.
ES2026966T3 (es) Procedimiento para la obtencion de 4-metil-4-fenil-1-penta--nales y su empleo como perfumantes.
MX9403382A (es) Xantinas sustituidas en la posicion 8 como agentes receptores selectivosde adenosina.
ES228022Y (es) Dispositivo para el montaje entre las partes de un soporte antivibrante, asi como para la fijacion del mismo.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 362526

Country of ref document: ES